Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.

Vaccine maker Moderna's chief executive officer Stephane Bancel will vacate his role as the company's chief commercial ...

Moderna chief executive officer Stéphane Bancel steps down as chief commercial officer, with president Stephen Hoge assuming ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

CEO Stéphane Bancel said the company is ahead of schedule on its plan to cut R&D costs by $1.1 billion over the next three years. Moderna (MRNA) reported better third-quarter results than ...

A source tells Bloomberg that Stephane Bancel will step down as the company’s Chief Commercial Officer, but retain the role of ...

Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.

CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

Moderna’s third-quarter financial results look far better than analysts anticipated, but the beat seems largely to reflect ...

Moderna shares rose Thursday morning after reporting better results than expected for the third quarter. The vaccine maker ...